A Case Report of Cervical Spine Infection Caused by Escherichia Coli
DOI:
https://doi.org/10.54097/wk2ycm71Keywords:
Cervical Spine Infection, Escherichia Coli, Anti-infective TherapyAbstract
Spinal infectious disease (SID) is an infectious condition caused by specific pathogens that invade the vertebral bodies, intervertebral discs, and adjacent paravertebral tissues through trauma, surgery, or hematogenous spread. Although the incidence of SID is relatively low, it often leads to quite severe consequences. In recent years, with the intensification of population aging, the increasing number of patients with diabetes, immunosuppression, and long-term vascular access, the advancement of imaging technologies and diagnostic methods, as well as the growth in the number of spinal surgeries, the incidence of spinal infections has shown a gradual upward trend. We report a case of a 59-year-old male patient with cervical spine infection. Combined with relevant literature, we discuss the clinical symptoms, key diagnostic points, and treatment principles of this condition, aiming to provide guidance for clinical practice.
Downloads
References
[1] Lener S, Hartmann S, Barbagallo GMV, et al. Management of spinal infection: a review of the literature. Acta Neurochir (Wien). 2018;160(3):487-496.
[2] Mylona E, Samarkos M, Kakalou E, et al. Pyogenic vertebral osteomyelitis: a systematic review of clinical characteristics. Semin Arthritis Rheum. 2009;39 (1):10–17.
[3] Stuer C, Stoffel M, Hecker J, et al. A staged treatment algorithm for spinal infections. J Neurol Surg A Cent Eur Neurosurg. 2013;74 (2):87–95.
[4] Schimmer RC, Jeanneret C, Nunley PD, Jeanneret B. Osteomyelitis of the cervical spine: A potentially dramatic disease. J Spinal Disord Tech. 2002;15:110–117.
[5] Tsantes A, Papadopoulos DV, Lytras T, et al. Association of malnutrition with surgical site infection following spinal surgery: Systematic review and meta-analysis [J]. Hosp Infect. 2020;104:111-119.
[6] Al-Nammari SS, Lucas JD, Lam KS. Hematogenous Methicillin-Resistant Staphylococcus Aureus Spondylodiscitis. Spine. 2007;32:2480–2486.
[7] Lener S, Hartmann S, Barbagallo GMV, Certo F, Thomé C, Tschugg A. Management of spinal infection: a review of the literature. Acta Neurochir (Wien). 2018 Mar;160 (3):487-496.
[8] Kim CJ, Kang SJ, Choe PG, Park WB, Jang HC, Jung SI, Song KH, Kim ES, Kim HB, Oh MD, Park KH, Kim NJ. Which tissues are best for microbiological diagnosis in patients with pyogenic vertebral osteomyelitis undergoing needle biopsy? Clin Microbiol Infect. 2015 Oct;21 (10):931-5.
[9] Berbari EF, Kanj SS, Kowalski TJ, Darouiche RO, Widmer AF, Schmitt SK, Hendershot EF, Holtom PD, Huddleston PM 3rd, Petermann GW, Osmon DR; Infectious Diseases Society of America. 2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adults. Clin Infect Dis. 2015 Sep 15;61 (6):e26-46.
[10] Bernard L, Dinh A, Ghout I, Simo D, Zeller V, Issartel B, Le Moing V, Belmatoug N, Lesprit P, Bru JP, Therby A, Bouhour D, Dénes E, Debard A, Chirouze C, Fèvre K, Dupon M, Aegerter P, Mulleman D; Duration of Treatment for Spondylodiscitis (DTS) Study Group. Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial. Lancet. 2015 Mar 7;385 (9971):875-82.
[11] Patel AR, Alton TB, Bransford RJ, Lee MJ, Bellabarba CB, Chapman JR. Spinal epidural abscesses: risk factors, medical versus surgical management, a retrospective review of 128 cases. Spine J. 2014 Feb 1;14 (2):326-30.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

